The Barbarian
DP Veteran
- Joined
- Jan 16, 2011
- Messages
- 1,265
- Reaction score
- 277
- Gender
- Male
- Political Leaning
- Conservative
The only problems that Pharma ran into was that they wanted to increase profit margins. They chose not to make the drug back in 2007 despite encouragement from the FDA.
Some times the arguments of anti business people like you amaze me.
First you say Pharma just wants to increase profits, seeing the new inhalers are going to do that, wouldn't have have increased profits back in 2007 as well? Wouldn't they have enjoyed those increased profits for the last 4 years ? Common business sense says that if you have a product that is going to make you more in profit, you get it to the market as fast as you can.
Seeing they didn't do this, one could just as easily say that Pharma kept making this product and putting in on shelves because it was more affordable and helped people at the same time. I realize that you won't and can't accept such a thing, because it doesn't paint big business as a villain'
Another thing seeing you seem to “know” this increase in price is for nothing but profits, perhaps you could direct me to the site showing that this new propellant is the same cost to the manufacturer as the old one ? Or that the same amount of propellant can be used per inhaler? Are there any handling or storage requirements that are different for the new propellant ?
That's a short list of things that might have something to do with the increased in costs, but I'm sure you have all that data at your fingertips seeing you seem to know that the increase in cost is for purely profitable reasons and nothing else.